Method for screening high-ovulation donor ewes and use thereof

By detecting the activity of gamma-glutamyl transferase, alkaline phosphatase, and platelet count in the blood of ewes, the problem of lack of standardization in oocyte donor selection has been solved, enabling efficient screening of high-producing oocyte donor ewes and improving embryo production efficiency and economic benefits.

WO2026232890A1PCT designated stage Publication Date: 2026-11-12CHINA AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2026/076106
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-07
Filing Date
2026-01-30
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

In existing technologies, the selection of oocyte donor animals lacks standardized procedures, resulting in large differences in the number of oocytes, which increases breeding costs and reduces economic benefits.

Method used

By detecting gamma-glutamyl transferase activity, alkaline phosphatase activity, and platelet count in ewe blood samples, and comparing these indicators with thresholds, high-producing ewe donors can be screened.

Benefits of technology

This method enables efficient and accurate selection of high-producing ewe donors, improves embryo production efficiency, reduces breeding costs, and enhances economic benefits.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2026076106_12112026_PF_FP_ABST
    Figure CN2026076106_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A method for screening high-ovulation donor ewes and the use thereof. By using γ-glutamyl transpeptidase activity, alkaline phosphatase activity or platelet count as evaluation indicators, a standardized method for screening high-ovulation donor ewes is established, which avoids the problems of low and highly variable ovulation numbers in donor ewes caused by subjective judgment alone in conventional methods, and effectively screens donor ewes, thereby improving embryo production efficiency, reducing labor and material inputs, and greatly saving breeding costs. The method has the advantages of simple operation, high accuracy, high efficiency, convenience in promotion and use, etc.
Need to check novelty before this filing date? Find Prior Art

Description

A method for screening high-producing egg-producing donor ewes and its application

[0001] Cross-references to related applications

[0002] This application claims priority to application number CN202510584403.3, filed on May 7, 2025, entitled “A method for screening high-producing ewe donors and its application”, the contents of which are incorporated herein by reference in their entirety. Technical Field

[0003] This disclosure pertains to the field of livestock breeding technology, and in particular relates to a method for screening high-producing egg donor ewes and its application. Background Technology

[0004] Embryo engineering technology refers to modern biotechnology that involves various micromanipulations and treatments of early animal embryos or gametes (sperm and eggs). It includes in vitro fertilization, embryo transfer, embryo splitting, embryo cryopreservation, sex control, and nuclear transfer. Through embryo production and transfer techniques, the reproductive potential of superior breeding ewes can be fully realized, increasing their annual offspring production by 30-40 times, thereby improving ewe reproductive efficiency. Furthermore, embryo engineering technology can shorten the breeding cycle of ewes, accelerate the breeding process, and increase the efficiency of developing new sheep breeds by 50%-70%. Embryo engineering technology has become an essential supporting technology for building a strong seed industry.

[0005] The selection of oocyte donor animals is a crucial step in embryo engineering, as oocytes are the starting point of embryonic development, and their quantity and quality directly affect the developmental potential of the embryo and the success rate of embryo engineering. In actual production, the number of ovulations varies significantly among different donor ewes after hormone induction, with some even failing to ovulate. This leads to increased breeding costs, reduced economic benefits, and a waste of human resources. Conventional methods for selecting oocyte donor animals rely on subjective evaluation, with evaluation indicators mainly including body condition, disease presence, age, parity, breed, and pedigree, lacking standardized procedures.

[0006] Therefore, establishing more efficient, accurate, and standardized methods for screening donor animals is an urgent problem to be solved in the field of livestock breeding. Summary of the Invention

[0007] To address at least some of the technical problems in the prior art, this disclosure provides a method for screening high-producing donor ewes and its application. Specifically, this disclosure includes the following.

[0008] A first aspect of this disclosure provides a method for screening high-ovulation donor ewes, comprising the following steps:

[0009] (1) Prepare blood samples from ewes;

[0010] (2) Detect the γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in the blood sample and obtain their respective detection values;

[0011] (3) Based on the respective detection values, identify high-producing egg donor ewes.

[0012] In some embodiments, the method for screening high-producing donor ewes according to the present disclosure includes step (3) of comparing the respective detection values ​​with their corresponding thresholds.

[0013] In some embodiments, according to the method for screening high-producing donor ewes as described in this disclosure, a ewe is identified as a high-producing donor ewe when the detected value of γ-glutamyl transferase activity is ≥ its corresponding threshold, the detected value of alkaline phosphatase activity is ≥ its corresponding threshold, and / or the detected value of platelet count is ≤ its corresponding threshold.

[0014] In some embodiments, the method for screening high-producing donor ewes according to this disclosure, wherein the threshold is a value statistically obtained from a sample group of donor ewes of similar age.

[0015] In some embodiments, the method for screening high-producing donor ewes according to this disclosure is wherein the threshold is a value statistically obtained from a sample group comparable to the donor ewe population.

[0016] In some embodiments, the method for screening high-producing oviparous donor ewes according to the present disclosure includes sheep or goats.

[0017] In some embodiments, the method for screening high-producing donor ewes according to this disclosure further includes a step of separating serum before detecting gamma-glutamyl transferase activity and alkaline phosphatase activity.

[0018] In some embodiments, the method for screening high-producing oviparous donor ewes according to this disclosure includes a blood sample derived from veterinary blood of the ewe.

[0019] A second aspect of this disclosure provides the application of the method described in the first aspect in the propagation of superior sheep breeds or in vitro embryo production.

[0020] A third aspect of this disclosure provides a kit for screening high-producing oviposition donor ewes, comprising reagents for detecting gamma-glutamyl transferase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples.

[0021] A fourth aspect of this disclosure provides an apparatus for screening high-producing donor ewes, comprising:

[0022] The data acquisition unit is configured to acquire detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples.

[0023] The data processing unit is configured to use the detected values ​​to identify high-producing egg-producing donor ewes.

[0024] In some embodiments, the data processing unit of the apparatus for screening high-producing ewe donors according to the present disclosure further includes a preset threshold for comparing the detected value with a corresponding threshold.

[0025] A fifth aspect of this disclosure provides a computer-readable storage medium storing a computer program that, when executed by a processor, is implemented as follows:

[0026] Obtain the detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in ewe blood samples;

[0027] The detection values ​​are used to identify high-producing egg-producing ewes.

[0028] This disclosure utilizes gamma-glutamyl transferase activity, alkaline phosphatase activity, or platelet count as evaluation indicators to establish a standardized method for identifying and screening high-producing donor ewes. This avoids the problem of conventional methods relying solely on subjective judgment, which can lead to low and inconsistent ovulation rates among donor ewes. This method can effectively screen donor ewes, improve embryo production efficiency, reduce labor and material inputs, significantly save on breeding costs, and thus improve economic benefits. It is of great significance for advancing livestock embryo production technology. Furthermore, this method has the advantages of simple operation, high accuracy, high efficiency, and ease of promotion and application. Attached Figure Description

[0029] Figure 1 shows the AUC assessment results using γ-glutamyl transpeptidase activity, alkaline phosphatase activity, or platelet count as criteria for selecting donor ewes.

[0030] Figure 2 illustrates the technical roadmap of this disclosure. Detailed Implementation

[0031] Various exemplary embodiments of this disclosure are now described in detail. This detailed description should not be considered as a limitation of this disclosure, but rather as a more detailed description of certain aspects, features, and implementations of this disclosure.

[0032] It should be understood that the terminology used in this disclosure is for describing particular embodiments only and is not intended to limit the disclosure. Furthermore, for numerical ranges in this disclosure, it should be understood that an upper and lower limit of the range and each intermediate value between them are specifically disclosed. Every smaller range between any stated value or intermediate value within a stated range, and any other stated value or intermediate value within said range, is also included in this disclosure. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.

[0033] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure pertains. While this disclosure describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may be used in implementation or testing of this disclosure. All references in this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.

[0034] Methods for selecting high-producing egg-producing donor ewes

[0035] One aspect of this disclosure provides a method for screening high-ovulation donor ewes, the method comprising the following steps:

[0036] (1) Prepare blood samples from ewes;

[0037] (2) Detect the γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in the blood sample and obtain their respective detection values;

[0038] (3) Based on the respective detection values, identify high-producing egg donor ewes.

[0039] In a preferred embodiment, step (3) of this disclosure includes comparing the respective detection values ​​with their corresponding thresholds. When the detection value of γ-glutamyl transferase activity is ≥ its corresponding threshold, the detection value of alkaline phosphatase activity is ≥ its corresponding threshold, and / or the detection value of platelet count is ≤ its corresponding threshold, the ewe is confirmed as a high-producing egg donor ewe.

[0040] In this disclosure, the threshold is a value obtained statistically from a sample group with an age equivalent to that of the donor ewes, or the threshold is a value obtained statistically from a sample group with a population equivalent to that of the donor ewes.

[0041] In a preferred embodiment, the threshold values ​​for γ-glutamyl transferase activity are 61.85 U / L, for alkaline phosphatase activity are 73.85 U / L, and for platelet count are 280 × 10⁻⁶. 9 / L.

[0042] In a preferred embodiment, when the detected value of γ-glutamyl transferase activity is ≥61.85 U / L, the detected value of alkaline phosphatase activity is ≥73.85 U / L, and / or the detected value of platelet count is ≤280×10⁻⁶, the platelet count is further specified. 9 When / L, the ewe is confirmed to be a high-producing egg donor ewe.

[0043] In this disclosure, serum gamma-glutamyl transferase activity, serum alkaline phosphatase activity, and blood platelet count can be used as individual evaluation indicators, or any combination of two or three of them can be used to screen high-producing egg donor ewes, without any particular limitation.

[0044] In one specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0045] (1) Collect blood samples from ewes, let them stand and centrifuge to obtain serum;

[0046] (2) Detect serum γ-glutamyl transpeptidase activity and obtain the detection value;

[0047] (3) When the detected value of the γ-glutamyl transpeptidase activity is ≥61.85U / L, the ewe is confirmed to be a high-producing egg donor ewe.

[0048] In another specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0049] (1) Collect blood samples from ewes, let them stand and centrifuge to obtain serum;

[0050] (2) Detect serum alkaline phosphatase activity and obtain the detection value;

[0051] (3) When the alkaline phosphatase activity is ≥73.85 U / L, the ewe is confirmed as a high-producing egg donor ewe.

[0052] In yet another specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0053] (1) Collect blood samples from ewes;

[0054] (2) Detect the platelet count in the blood sample and obtain the detection value;

[0055] (3) When the platelet count is ≤280×10 9 If / L, then the ewe is confirmed to be a high-producing egg donor ewe.

[0056] In yet another specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0057] (1) Collect blood samples from ewes, let them stand and centrifuge to obtain serum;

[0058] (2) Detect serum γ-glutamyl transpeptidase activity and serum alkaline phosphatase activity, and obtain the detection values;

[0059] (3) When the detected value of the γ-glutamyl transpeptidase activity is ≥61.85U / L and the detected value of the alkaline phosphatase activity is ≥73.85U / L, the ewe is confirmed as a high-producing egg donor ewe.

[0060] In yet another specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0061] (1) Collect blood samples from ewes, let them stand and centrifuge to obtain serum;

[0062] (2) Detect the serum γ-glutamyl transpeptidase activity and blood platelet count in the blood sample to obtain the detection values;

[0063] (3) When the detected value of the γ-glutamyl transpeptidase activity is ≥61.85 U / L and the detected value of the platelet count is ≤280×10⁻⁶. 9 When / L, the ewe is confirmed to be a high-producing egg donor ewe.

[0064] In yet another specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0065] (1) Collect blood samples from ewes, let them stand and centrifuge to obtain serum;

[0066] (2) Detect the serum alkaline phosphatase activity and blood platelet count in the blood sample to obtain the detection values;

[0067] (3) When the alkaline phosphatase activity is ≥73.85 U / L and the platelet count is ≤280×10⁻⁶. 9 When / L, the ewe is confirmed to be a high-producing egg donor ewe.

[0068] In yet another specific implementation, the method for screening high-producing donor ewes includes the following steps:

[0069] (1) Collect blood samples from ewes, let them stand and centrifuge to obtain serum;

[0070] (2) Detect the serum γ-glutamyl transpeptidase activity, alkaline phosphatase activity and blood platelet count in the blood sample to obtain the detection values;

[0071] (3) When the detected value of γ-glutamyl transferase activity is ≥61.85 U / L, the detected value of alkaline phosphatase activity is ≥73.85 U / L, and the detected value of platelet count is ≤280×10 9 When / L, the ewe is confirmed to be a high-producing egg donor ewe.

[0072] In this disclosure, the breed of the ewe is not particularly limited, and examples include, but are not limited to, sheep and goats.

[0073] In the above steps involving settling and centrifugation, the settling time is 20-70 minutes, preferably 25-65 minutes, and even more preferably 30-60 minutes, for example, 30, 35, 40, 45, 50, 55, or 60 minutes. The centrifugation speed is 2000-5000 r / min, preferably 2200-4800 r / min, even more preferably 2400-4600 r / min, more preferably 2600-4400 r / min, even more preferably 2800-4200 r / min, and even more preferably 3000-4000 r / min, for example, 3000, 3200, 3400, 3600, 3800, or 4000 r / min.

[0074] In this disclosure, the methods for detecting γ-glutamyl transferase and alkaline phosphatase activities are not particularly limited, and methods known in the art can be used, including but not limited to colorimetric methods, fluorescent probe methods, and enzyme-linked immunosorbent assays. The methods for detecting platelet counts are not particularly limited, and methods known in the art can be used, including but not limited to microscopic counting, flow cytometry, impedance spectroscopy, and light scattering.

[0075] application

[0076] One aspect of this disclosure is the application of the method described herein in the propagation of superior sheep breeds or in embryo production.

[0077] This invention uses blood indicators to screen for high-quality donor ewes, which can be used for subsequent breeding or embryo production. This can rapidly increase the number of high-quality breeding sheep, greatly improve the production efficiency of high-quality embryos, and thus enhance the breeding benefits.

[0078] Reagent test kit

[0079] One aspect of this disclosure provides a kit for screening high-producing oviposition donor ewes, comprising reagents for detecting gamma-glutamyl transferase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples.

[0080] In one specific implementation, the kit further includes at least one of an instruction manual, a standard, or a threshold card, wherein the instruction manual included in the kit describes how to perform the screening steps and judgment rules for high-producing donor ewes.

[0081] The reagents used in the kits disclosed herein are not particularly limited, as long as they are capable of detecting gamma-glutamyl transferase activity, alkaline phosphatase activity, and / or platelet count. For example, reagents for measuring gamma-glutamyl transferase activity include L-γ-glutamyl-3-carboxy-4-nitroaniline, glycylglycine, and magnesium ions. Reagents for measuring alkaline phosphatase activity include p-nitrophenyl phosphate, 2-amino-2-methyl-1-propanol (AMP) buffer, and magnesium ions. Reagents for measuring platelet count include platelet-specific antibodies, such as fluorescently labeled anti-CD41 and anti-CD61 antibodies.

[0082] Device

[0083] One aspect of this disclosure provides an apparatus for screening high-producing donor ewes, comprising:

[0084] The data acquisition unit is configured to acquire detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples.

[0085] The data processing unit is configured to use the detected values ​​to identify high-producing egg-producing donor ewes.

[0086] In some embodiments, the data processing unit of the apparatus for screening high-producing ewe donors according to the present disclosure further includes stored preset thresholds for comparing the detected values ​​with corresponding thresholds.

[0087] In some embodiments, the apparatus for screening high-producing donor ewes according to the present disclosure further includes a display unit (e.g., a display screen) to display the screening results of high-producing donor ewes.

[0088] One aspect of this disclosure provides a computer-readable storage medium storing a computer program that, when executed by a processor, is implemented as follows:

[0089] Obtain the detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in ewe blood samples;

[0090] The detection values ​​are used to identify high-producing egg-producing ewes.

[0091] Example 1

[0092] The following illustrates the process of establishing a method for screening high-producing egg donor ewes.

[0093] 1. Experimental Materials

[0094] Unless otherwise specified, the methods used in this embodiment are conventional methods known to those skilled in the art. Unless otherwise specified, all reagents, consumables, and other materials used are commercially available products.

[0095] 2. Experimental Methods

[0096] 2.1 Selection of breeding ewes

[0097] Select 400 individuals from a large flock of breeding ewes that have a clear pedigree, are healthy, in good condition, have normal estrous cycles, and are free from reproductive disorders. These individuals should be 2-4 years old and weigh approximately 45-55 kg.

[0098] 2.2 Collection of blood samples from sheep jugular veins

[0099] Grasp the sheep's horns or ears with both hands, tilting its head upwards and towards the opposite side of the blood collection site. Clip the hair and disinfect the collection site. With your left thumb, press down on the lower part of the jugular groove to make the jugular vein as engorged and distended as possible; with your right thumb or forefinger, palpate for the blood vessel in the jugular groove. Quickly insert the needle into the skin and blood vessel at a 30-45° angle at the insertion point in the jugular groove. If blood return is observed, insert the needle forward 1-2 cm parallel to the skin. After collecting 10 mL of blood, disinfect with 5% iodine tincture.

[0100] 2.3 Complete blood count (CBC)

[0101] A fully automated blood cell analyzer was used to measure routine blood parameters, including white blood cell count (WBC), red blood cell count (RBC), hemoglobin (HGB), hematocrit (HCT), and platelet count (PLT).

[0102] 2.4 Serum Sample Preparation and Collection

[0103] Use 5 mL of jugular vein blood sample from a donor ewe, leave at room temperature for 30-60 minutes, centrifuge at 3500 r / min for 10 minutes to separate the serum, aliquot into 1.5 mL centrifuge tubes, and freeze at -20℃.

[0104] 2.5 Serum Biochemical Indicators Detection

[0105] Serum biochemical indicators, including gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), total protein (TP), albumin (ALB), globulin (GLB), creatinine (Cr), urea, potassium (K+), serum calcium (sCa), serum phosphorus (sP), serum magnesium (sMg), triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), glucose (Glu), β-hydroxybutyrate (β-HB), creatine kinase (CK), and lactate dehydrogenase (LDH), were measured using a fully automated biochemical analyzer.

[0106] 2.6 Serum antioxidant index detection

[0107] Serum antioxidant-related indicators, including total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px) activity, malondialdehyde (MDA) content, and total superoxide dismutase (T-SOD) activity, were detected using reagent kits produced by Nanjing Jiancheng Biotechnology Research Institute.

[0108] 2.7 Serum Hormone Level Detection

[0109] Serum hormone levels, including follicle-stimulating hormone (FSH), estrogen (E2), and progesterone (P4), were detected using an ELISA kit. The OD value of each serum sample was measured at a wavelength of 450 nm using a microplate reader.

[0110] 2.8 Follicle-stimulating hormone induction in donor ewes

[0111] On any day of the ewe's estrus cycle, administer progesterone suppositories into the vagina for 10 days. Hormone induction begins on the 10th day, following this procedure: inject FSH once daily for 2 consecutive days, 240 IU each time.

[0112] 2.9 Live egg collection from donor ewes

[0113] Following the second FSH injection, the ewes were fasted and deprived of food and water. Forty-eight hours later, the donor ewes were anesthetized and restrained in a sling for laparoscopic oocyte retrieval. After oocyte retrieval, the progesterone suppositories were removed, and the total number of oocytes retrieved from each donor ewe was recorded.

[0114] Based on the total number of eggs recovered, the donor ewes were divided into a high-egg-retrieval group (total number of eggs > 15) and a low-egg-retrieval group (total number of eggs < 10).

[0115] 2.10 Data Statistics

[0116] Experimental data were recorded using Excel, and statistical software was used for difference analysis.

[0117] 3. Test Results

[0118] 3.1 Analysis of routine blood parameters of donor ewes in high and low oocyte retrieval groups

[0119] As shown in Table 1, the platelet count in the blood of donor ewes in the high oocyte retrieval group was 182.53±8.16, which was significantly lower than that in the low oocyte retrieval group (363.11±11.47) (P<0.01). There were no differences in other indicators between the two groups (P>0.05).

[0120] Table 1. Blood routine indicators of donor ewes in high and low oocyte retrieval groups Note: ** indicates a highly significant difference (P<0.01).

[0121] 3.2 Analysis of serum antioxidant indicators in donor ewes of high and low oocyte retrieval groups

[0122] As shown in Table 2, there were no differences in various antioxidant indicators in the serum of donor ewes in the high and low oocyte retrieval groups (P>0.05).

[0123] Table 2. Serum antioxidant indices of donor ewes in high and low oocyte retrieval groups

[0124] 3.3 Serum biochemical indicators analysis of donor ewes in high and low oocyte retrieval groups

[0125] Table 3 shows that the serum gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) activities of donor ewes in the high oocyte retrieval group were 74.78±2.15 and 95.23±2.06, respectively, which were significantly higher than those in the low oocyte retrieval group (52.14±1.38, 51.46±1.67) (P<0.01). There were no significant differences in other serum biochemical indicators between the two groups.

[0126] Table 3 Serum biochemical indicators of donor ewes in high and low oocyte retrieval groups Note: ** indicates a highly significant difference (P<0.01).

[0127] 3.4 Analysis of serum hormone levels in donor ewes in high and low oocyte retrieval groups

[0128] As shown in Table 4, there were no differences in the serum levels of various hormones in donor ewes between the high and low oocyte retrieval groups (P>0.05).

[0129] Table 4. Serum hormone levels of donor ewes in high and low oocyte retrieval groups.

[0130] 3.5 Serum gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP) activity, and blood platelet count were used as screening criteria for donor ewes.

[0131] Receiver operating characteristic (ROC) curves were used to assess the discriminative power of serum gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP) activity, and blood platelet count as selection criteria for donor ewes. The area under the ROC curve (AUC) was then used to describe the ability of these indicators to differentiate donor ewes. An AUC > 0.7 indicates that the target indicator has a certain degree of accuracy in the selection criteria; in this example, 0.8 was used as a benchmark to improve the accuracy of the criteria. Analysis of the ROC curves revealed that the AUCs for serum GGT activity, serum ALP activity, and blood platelet count all reached 0.92, 0.94, and 0.92 respectively (Figure 1, Table 5). This demonstrates that serum GGT, ALP activity, and blood platelet count can serve as high-quality selection criteria for donor ewes. Specific data are shown in Table 5.

[0132] Table 5. Serum γ-glutamyl transferase, alkaline phosphatase activity, and platelet count as threshold data for donor ewes.

[0133] Choosing any of these thresholds involves a trade-off between sensitivity and specificity.

[0134] As shown in Table 5, the sensitivity of γ-glutamyl transferase activity was 75.78%, the specificity was 93.75%, and the Youden index was 0.701; the sensitivity of alkaline phosphatase activity was 96.27%, the specificity was 86.25%, and the Youden index was 0.813; the sensitivity of platelet count was 95.65%, the specificity was 82.5%, and the Youden index was 0.824. In other words, donor ewe serum γ-glutamyl transferase activity should be greater than 61.85 U / L, serum alkaline phosphatase activity greater than 73.85 U / L, or blood platelet count less than 280 × 10⁻⁶. 9 When the ratio is / L, the donor ewe can be selected for production use.

[0135] 3.6 Validation of serum gamma-glutamyl transferase, alkaline phosphatase activity, and blood platelet count as screening criteria

[0136] To test the accuracy of serum gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), and blood platelet count as screening criteria, 100 ewes were selected for predictive validation. The validation results are shown in Table 6. The accuracy of serum GGT, ALP, and blood platelet count as screening criteria were 91.01%, 96.47%, and 93.41%, respectively. These results demonstrate that the indicators proposed in this embodiment are highly accurate for screening donor ewes.

[0137] Table 6. Validation of serum gamma-glutamyl transferase, alkaline phosphatase activity, and blood platelet count as screening criteria.

[0138] In summary, this disclosure, through the analysis of a large amount of experimental data, has yielded a method for screening donor ewes, namely, detecting serum gamma-glutamyl transferase activity, serum alkaline phosphatase activity, or blood platelet count in donor ewes, and screening for high-quality donor ewes based on standard values.

[0139] Example 2

[0140] This embodiment illustrates a kit for screening high-producing ewe donors, which includes at least reagents for detecting γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in ewe blood samples, and instructions for explaining the steps for screening high-producing ewe donors.

[0141] This kit may include other reagents that enable routine detection through various assay types, such as ELISA assays, immunoassays, protein chips or microarrays, DNA / RNA chips or microarrays, RT-PCR, third-generation sequencing, mass spectrometry, immunohistochemistry, flow cytometry, or cell screening.

[0142] In addition to the components described above, the kit disclosed herein may also include precautions related to the regulation of the manufacture, use, or sale of diagnostic kits, in a manner prescribed by government agencies. Furthermore, the kit disclosed herein may also provide detailed instructions for use, storage, and troubleshooting. The kit may optionally be housed in a suitable device, preferably for high-throughput robotic operation.

[0143] In some embodiments, the components of the kit disclosed herein may be provided as dry powder. When the reagents and / or components are provided as dry powder, the powder can be reconstituted by adding a suitable solvent. It is contemplated that the solvent may also be provided in another container. The container typically includes at least one vial, test tube, flask, bottle, syringe, and / or other container means in which the solvent may optionally be placed in equal portions. The kit may also include means for containing a second container of sterile, pharmaceutically acceptable buffers and / or other solvents.

[0144] In some embodiments, the components of the kit disclosed herein may be provided in solution form, such as an aqueous solution. When present in aqueous solution form, the concentration or content of these components can be readily determined by those skilled in the art according to different needs. For example, for storage purposes, the component concentration may be higher, and when in operation or in use, the concentration can be reduced to the working concentration, for example, by diluting the higher concentration solution.

[0145] When a kit contains more than one component, it typically includes a second, third, or other additional container for holding other components separately. Additionally, combinations of multiple components can be contained within the container.

[0146] Example 3

[0147] This embodiment illustrates a device for screening high-producing donor ewes, which includes at least:

[0148] The data acquisition unit is configured to acquire detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples.

[0149] A data processing unit is configured to use the detected values ​​to identify high-producing egg-producing donor ewes;

[0150] In some implementations, the data processing unit further includes a preset threshold for comparing the detected value with a corresponding threshold.

[0151] Those skilled in the art will understand that the various exemplary embodiments described in this disclosure can be implemented by software or by combining software with necessary hardware. Therefore, specific embodiments according to this disclosure can be embodied in the form of a software product, which can be stored on a non-volatile storage medium or a non-transitory computer-readable storage medium (such as a CD-ROM, USB flash drive, portable hard drive, etc.) or on a network, including several instructions to cause a computing device (such as a personal computer, server, mobile terminal, or network device, etc.) to execute the methods according to this disclosure.

[0152] In exemplary embodiments, the program product of this disclosure may employ any combination of one or more readable media. A readable medium may be a readable signal medium or a readable storage medium. A readable storage medium may be, for example, but not limited to, an electrical, magnetic, optical, electromagnetic, infrared, or semiconductor system, apparatus, or device, or any combination thereof. More specific examples of readable storage media include, but are not limited to: electrical connections having one or more wires, portable disks, hard disks, random access memory (RAM), read-only memory (ROM), erasable programmable read-only memory (EPROM or flash memory), optical fiber, portable compact disk read-only memory (CD-ROM), optical storage devices, magnetic storage devices, or any suitable combination thereof.

[0153] In this embodiment, the computer-readable storage medium stores a computer program that is implemented when executed by a processor:

[0154] Obtain the detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in ewe blood samples;

[0155] The detection values ​​are used to identify high-producing egg-producing ewes.

[0156] Accordingly, based on the same inventive concept, this disclosure also provides an electronic device.

[0157] In exemplary embodiments, the electronic device is manifested as a general-purpose computing device. Components of the electronic device may include, but are not limited to, at least one processor, at least one memory, and a bus connecting different system components (including the memory and the processor). The memory stores program code that can be executed by the processing unit, causing the processing unit to perform at least some steps of the methods described in this disclosure, wherein the processor includes at least the data processing unit described in this disclosure. The memory may include a readable medium in the form of volatile storage units, such as random access memory (RAM) and / or cache memory units, and may further include read-only memory (ROM).

[0158] The memory disclosed herein may also include a program / utility having a set (at least one) of program modules, including but not limited to: an operating system, one or more application programs, other program modules, and program data, each or some combination of these examples may include an implementation of a network environment.

[0159] A bus can represent one or more of several types of bus structures, including a memory bus or memory controller, a peripheral bus, a graphics acceleration port, a processing unit, or a local bus that uses any of the various bus structures.

[0160] Electronic devices can also communicate with one or more external devices (such as keyboards, pointing devices, Bluetooth devices, etc.), and with one or more devices that enable users to interact with the electronic device, and / or with any device that enables the electronic device to communicate with one or more other computing devices (such as routers, modems, etc.).

[0161] This communication can be achieved through input / output (I / O) interfaces. Furthermore, the electronic device can communicate with one or more networks (e.g., local area networks (LANs), wide area networks (WANs), and / or public networks, such as the Internet) via a network adapter. The network adapter communicates with other modules of the electronic device via a bus. It should be understood that, although not shown herein, other hardware and / or software modules can be used in conjunction with the electronic device, including but not limited to: microcode, device drivers, redundant processing units, external disk drive arrays, RAID systems, tape drives, and data backup storage systems.

[0162] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of this disclosure, and not to limit them. Although this disclosure has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features. These modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of this disclosure.

Claims

1. A method for screening high-producing egg-producing donor ewes, characterized in that, The method includes the following steps: (1) Prepare blood samples from ewes; (2) Detect the γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in the blood sample and obtain their respective detection values; (3) Based on the respective detection values, identify high-producing egg donor ewes.

2. The method for screening high-producing donor ewes according to claim 1, characterized in that, Step (3) includes comparing the respective detection values ​​with their corresponding thresholds.

3. The method for screening high-producing donor ewes according to claim 1, characterized in that, When the detected value of γ-glutamyl transferase activity is ≥ its corresponding threshold, the detected value of alkaline phosphatase activity is ≥ its corresponding threshold, and / or the detected value of platelet count is ≤ its corresponding threshold, the ewe is confirmed as a high-producing egg donor ewe.

4. The method for screening high-producing donor ewes according to claim 2, characterized in that, The threshold is a value obtained statistically from a sample group of donor ewes of similar age.

5. The method for screening high-producing donor ewes according to claim 2, characterized in that, The threshold is a value obtained statistically from a sample group comparable to the donor ewe population.

6. The method for screening high-producing donor ewes according to claim 1, characterized in that, The ewes include sheep or goats; Preferably, the step of separating serum is further included before detecting γ-glutamyl transpeptidase activity or alkaline phosphatase activity; Preferably, the blood sample is derived from venous blood from a ewe.

7. The application of the method according to any one of claims 1-6 in the propagation of superior sheep breeds or embryo production.

8. A kit for screening high-producing donor ewes, characterized in that, This includes reagents for detecting gamma-glutamyl transferase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples.

9. A device for screening high-producing donor ewes, characterized in that, include: The data acquisition unit is configured to acquire detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity, and / or platelet count in ewe blood samples. A data processing unit is configured to use the detected values ​​to identify high-producing egg-producing donor ewes; Preferably, the data processing unit stores a preset threshold for comparing the detected value with the corresponding threshold.

10. A computer-readable storage medium, characterized in that, It stores a computer program, which is implemented when executed by a processor: Obtain the detection values ​​of γ-glutamyl transpeptidase activity, alkaline phosphatase activity and / or platelet count in ewe blood samples; The detection values ​​are used to identify high-producing egg-producing ewes.